CN114715999A - 一种不溶于水但可以释放偏硅酸的能量石 - Google Patents
一种不溶于水但可以释放偏硅酸的能量石 Download PDFInfo
- Publication number
- CN114715999A CN114715999A CN202210486033.6A CN202210486033A CN114715999A CN 114715999 A CN114715999 A CN 114715999A CN 202210486033 A CN202210486033 A CN 202210486033A CN 114715999 A CN114715999 A CN 114715999A
- Authority
- CN
- China
- Prior art keywords
- energy stone
- water
- metasilicic acid
- stone body
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004575 stone Substances 0.000 title claims abstract description 53
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 title claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 11
- 229910052681 coesite Inorganic materials 0.000 claims abstract description 8
- 229910052906 cristobalite Inorganic materials 0.000 claims abstract description 8
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 8
- 229910052682 stishovite Inorganic materials 0.000 claims abstract description 8
- 229910052905 tridymite Inorganic materials 0.000 claims abstract description 8
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 8
- 229910052742 iron Inorganic materials 0.000 claims abstract description 6
- 229910052802 copper Inorganic materials 0.000 claims abstract description 5
- 229910052745 lead Inorganic materials 0.000 claims abstract description 4
- 210000004204 blood vessel Anatomy 0.000 abstract description 11
- 239000010703 silicon Substances 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000001815 facial effect Effects 0.000 abstract description 4
- 238000007790 scraping Methods 0.000 abstract description 4
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 2
- 208000019622 heart disease Diseases 0.000 abstract description 2
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000005259 measurement Methods 0.000 description 35
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 17
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 14
- 239000011701 zinc Substances 0.000 description 13
- 239000011133 lead Substances 0.000 description 12
- 239000010949 copper Substances 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 8
- 238000001228 spectrum Methods 0.000 description 8
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 7
- 230000037182 bone density Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000011787 zinc oxide Substances 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 230000003796 beauty Effects 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 235000012239 silicon dioxide Nutrition 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 210000002249 digestive system Anatomy 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000004519 grease Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 206010013082 Discomfort Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 2
- 229910000039 hydrogen halide Inorganic materials 0.000 description 2
- 239000012433 hydrogen halide Substances 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 208000025978 Athletic injury Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041738 Sports injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229910002026 crystalline silica Inorganic materials 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H7/00—Devices for suction-kneading massage; Devices for massaging the skin by rubbing or brushing not otherwise provided for
- A61H7/002—Devices for suction-kneading massage; Devices for massaging the skin by rubbing or brushing not otherwise provided for by rubbing or brushing
- A61H7/003—Hand-held or hand-driven devices
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/02—Treatment of water, waste water, or sewage by heating
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2305/00—Use of specific compounds during water treatment
- C02F2305/14—Additives which dissolves or releases substances when predefined environmental conditions are reached, e.g. pH or temperature
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Engineering & Computer Science (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种不溶于水但可以释放偏硅酸的能量石,包括能量石本体,所述能量石本体内含有Si、Fe、Cu、Zn和Pb元素,所述Si元素为SiO2,所述Fe元素为FeO,所述Cu元素为CuO,所述Zn元素为ZnO,所述Pb元素为PbO。通过由硅制造的能量石本体,将能量石本体在水中浸泡,能够提高水中的活性有益物质,提高最显著的是偏硅酸,偏硅酸能够软化人体血管,可使人的血管壁保持弹性,促进骨骼发育,缓解动脉硬化、心血管和心脏疾病,用60℃以上热水冲泡,能够将能量石本体中的硅激发,缓解湿寒凉给使用者带来的各种不适;同时可以将能量石本体佩戴在身上,也可以用于刮痧,还可以做成美容棒,用于面部美容。
Description
技术领域
本发明涉及能量石技术领域,具体为一种不溶于水但可以释放偏硅酸的能量石。
背景技术
能量石是提取高质量的天然火山岩里的72种稀有微量元素,经先进技术制造而成。能量石具有促进无聚集细胞、促进血液循环、提升免疫系统和分泌系统、有消灭和抵抗病菌的能力、增强细胞营养吸收和排毒、提高细胞的渗透性、保护脱氧核糖核酸(DNA),提防有所受损、有抗衰老的功能、帮助抵抗癌细胞、加强人体的生物场、防止电磁波影响人体健康的功效。许多世界级运动员佩戴能量石的情况显示,能量石能从一定程度提升身体力量,平衡度,柔韧度,精神注意力及帮助恢复因高强度运动带来的运动损伤。能量石能够减轻风湿症痛楚,帮助减少失眠状况,减轻肌肉酸痛,平衡高血压,还具有凉血止血、清平肝火的效力。
本发明提供了一种不溶于水但可以释放偏硅酸的能量石,可以佩戴在身上,也可以用于刮痧,还可以做成美容棒,对面部的美容也有帮助,在水中浸泡,还能够提高水中的活性有益物质,可让使用者缓解湿寒凉所带来的各种不适,使血管更富有弹性,骨密度更高,而且在浸泡后未检测出重金属
发明内容
鉴于现有技术中所存在的问题,本发明公开了一种不溶于水但可以释放偏硅酸的能量石,采用的技术方案是,包括能量石本体,所述能量石本体内含有Si元素、Fe、Cu、Zn和Pb元素,所述Si元素以SiO2形式存在,SiO2是一种无机物,硅原子和氧原子长程有序排列形成晶态二氧化硅,短程有序或长程无序排列形成非晶态二氧化硅,使能量石本体化学性质更加稳定,不跟水产生反应,也不与除氟、氟化氢以外的卤素、卤化氢以及硫酸、硝酸、高氯酸作用,SiO2能够使能量石本体不溶于水,恢复钙镁之间的必要平衡,使血管更富有弹性,骨密度更高,所述Fe元素以FeO形式存在,FeO是铁的氧化物之一,由氧化态为+2价的铁与氧共价结合,氧化亚铁属于立方晶系(类似于氯化钠晶体结构),每个铁原子周围连接着6个氧原子形成八面体型配位,每个氧原子周围也以同样的情况连接着6个铁原子,微量FeO起到参与运输和储存氧的作用,所述Cu元素以CuO形式存在,CuO是一种无机物,略显两性,稍有吸湿性,不溶于水和乙醇,易溶于酸,对热稳定,高温下分解出氧气,微量CuO对身体通常能够起到促进血液循环、活化神经、调节消化系统等效果,能够促进血液循环,下降血液的黏度,改善微循环系统,ZnO是锌的一种氧化物,ZnO是锌的一种氧化物,难溶于水,可溶于酸和强碱,氧化锌是锌的氧化物,是一种性质非常稳定的白色粉末,不溶于水,具有吸附油脂和水分的作用,微量ZnO对人体皮肤主要起到收敛、干燥和抑菌的作用,所述Pb元素以PbO形式存在,微量PbO对人体皮肤主要起到收敛、杀菌止痒的作用。
作为本发明的一种优选技术方案,所述Si元素含量为999789.19ppm,所述SiO2含量为999934.32ppm,整个能量石本体由硅制造,使血管更富有弹性,骨密度更高。
作为本发明的一种优选技术方案,所述Fe元素含量为157.68ppm,所述FeO含量为50.24ppm,微量的Fe元素参与运输和储存氧的作用。
作为本发明的一种优选技术方案,所述Cu元素含量为12.82ppm,所述CuO含量为3.94ppm,微量的Cu元素对身体通常能够起到促进血液循环、活化神经、调节消化系统等效果,能够促进血液循环,下降血液的黏度,改善微循环系统。
作为本发明的一种优选技术方案,所述Zn元素含量为22.26ppm,所述ZnO含量为6.78ppm,微量的Zn元素具有吸附油脂和水分的作用,对人体皮肤主要起到收敛、干燥和抑菌的作用。
作为本发明的一种优选技术方案,所述Pb元素含量为18.06ppm,所述PbO含量为4.73ppm,微量的Pb元素对人体皮肤主要起到收敛、杀菌止痒的作用。
本发明的有益效果:本发明通过由硅制造的能量石本体,将能量石本体在水中浸泡,能够提高水中的活性有益物质,如钙镁钠锌锶等,提高最显著的是偏硅酸,偏硅酸对人体具有良好的软化血管的功能,可使人的血管壁保持弹性,增加皮肤弹性,促进骨骼发育,对动脉硬化、心血管和心脏疾病能起到明显的缓解作用,用60℃以上热水冲泡,能够将能量石本体中的硅激发,提升水中硅元素指标,可让使用者缓解湿寒凉所带来的各种不适,使血管更富有弹性,骨密度更高,而且在浸泡后未检测出重金属;进一步的,可以将能量石本体佩戴在身上,也可以用于刮痧,还可以做成美容棒,对面部的美容也有帮助。
附图说明
图1为本发明能量石本体样品影响图;
图2为本发明第一次测量的测量条件1下的X-射线能谱图;
图3为本发明第一次测量的测量条件2下的X-射线能谱图;
图4为本发明第一次测量的测量条件3下的X-射线能谱图;
图5为本发明第一次测量的测量条件4下的X-射线能谱图;
图6为本发明第二次测量的测量条件1下的X-射线能谱图;
图7为本发明第二次测量的测量条件2下的X-射线能谱图;
图8为本发明第二次测量的测量条件3下的X-射线能谱图;
图9为本发明第二次测量的测量条件4下的X-射线能谱图。
具体实施方式
实施例1
如图1至图9所示,本发明公开了一种不溶于水但可以释放偏硅酸的能量石,采用的技术方案是,包括能量石本体,所述能量石本体内含有Si、Fe、Cu、Zn和Pb元素,所述Si元素以SiO2形式存在,SiO2使能量石本体化学性质更加稳定,不跟水产生反应,也不与除氟、氟化氢以外的卤素、卤化氢以及硫酸、硝酸、高氯酸作用,并能够恢复钙镁之间的必要平衡,使血管更富有弹性,骨密度更高,所述Fe元素以FeO形式存在,微量FeO起到参与运输和储存氧的作用,所述Cu元素以CuO形式存在,微量CuO对身体通常能够起到促进血液循环、活化神经、调节消化系统等效果,能够促进血液循环,下降血液的黏度,改善微循环系统,所述Zn元素以ZnO形式存在,微量ZnO具有吸附油脂和水分的作用,对人体皮肤主要起到收敛、干燥和抑菌的作用,所述Pb元素以PbO形式存在,微量PbO对人体皮肤主要起到收敛、杀菌止痒的作用。
作为本发明的一种优选技术方案,所述Si元素含量为999789.19ppm,所述SiO2含量为999934.32ppm,整个能量石本体由硅制造,使血管更富有弹性,骨密度更高。
作为本发明的一种优选技术方案,所述Fe元素含量为157.68ppm,所述FeO含量为50.24ppm,微量的Fe元素参与运输和储存氧的作用。
作为本发明的一种优选技术方案,所述Cu元素含量为12.82ppm,所述CuO含量为3.94ppm,微量的Cu元素对身体通常能够起到促进血液循环、活化神经、调节消化系统等效果,能够促进血液循环,下降血液的黏度,改善微循环系统。
作为本发明的一种优选技术方案,所述Zn元素含量为22.26ppm,所述ZnO含量为6.78ppm,微量的Zn元素具有吸附油脂和水分的作用,对人体皮肤主要起到收敛、干燥和抑菌的作用。
作为本发明的一种优选技术方案,所述Pb元素含量为18.06ppm,所述PbO含量为4.73ppm,微量的Pb元素对人体皮肤主要起到收敛、杀菌止痒的作用。
下面在四个测量条件下对能量石本体进行两次X-射线能谱测量:
第一次测量的测量条件:
测量条件1 | 测量条件2 | 测量条件3 | 测量条件4 | |
测量时间(秒) | 100 | 100 | 100 | 100 |
备用时间(秒) | 83 | 97 | 91 | 94 |
Collimator | 8.0mm | 8.0mm | 8.0mm | 8.0mm |
X-光管电压(kV) | 15 | 15 | 50 | 50 |
X-光管电流(μA) | 1000 | 1000 | 1000 | 1000 |
滤波器 | OFF | Cr用 | Pb用 | Cd用 |
塑料薄膜 | OFF | OFF | OFF | OFF |
周边环境 | 充气 | 充气 | 充气 | 充气 |
PeakingTime | 1.0usec | 1.0usec | 1.0usec | 1.0usec |
元素分析结果
Si | 999783.57(ppm) |
Fe | 158.25(ppm) |
Cu | 17.29(ppm) |
Zn | 24.50(ppm) |
Pb | 16.40(ppm) |
化合物分析结果
SiO<sub>2</sub> | 999932.51(ppm) |
FeO | 50.42(ppm) |
CuO | 5.31(ppm) |
ZnO | 7.46(ppm) |
PbO | 4.29(ppm) |
第一次测量的四种测量条件下的X-射线能谱图如图2-图5所示;
第二次测量的测量条件:
测量系统 | SEA1200VXID_1407 |
分析档案 | 全元素分析-A-100s.bfp |
X-射线产生元素 | Rh |
测量条件1 | 测量条件2 | 测量条件3 | 测量条件4 | |
测量时间(秒) | 100 | 100 | 100 | 100 |
备用时间(秒) | 83 | 97 | 90 | 94 |
Collimator | 8.0mm | 8.0mm | 8.0mm | 8.0mm |
X-光管电压(kV) | 15 | 15 | 50 | 50 |
X-光管电流(μA) | 1000 | 1000 | 1000 | 1000 |
滤波器 | OFF | Cr用 | Pb用 | Cd用 |
塑料薄膜 | OFF | OFF | OFF | OFF |
周边环境 | 充气 | 充气 | 充气 | 充气 |
PeakingTime | 1.0usec | 1.0usec | 1.0usec | 1.0usec |
元素分析结果
Si | 999789.19(ppm) |
Fe | 157.68(ppm) |
Cu | 12.82(ppm) |
Zn | 22.26(ppm) |
Pb | 18.06(ppm) |
化合物分析结果
第一次测量的四种测量条件下的X-射线能谱图如图6-图9所示,测量结果显示元素和化合物指标符合GB 8537-2018要求。
本发明的工作原理:使用能量石时,可以将能量石浸泡在25℃的水中,72小时之后水性指标:偏硅酸≥38mg/L、锶≥0.038mg/L、锌≥0.001mg/L、钾≥0.020mg/L、钙≥5mg/L、镁≥0.013mg/L、钠≥0.019mg/L,铜、锰、银、总铬、铅和镉均未检测出,PH值为7.7±0.5;用60℃以上热水冲泡能量石,可以将能量石中的硅激发,提升水中硅元素指标,可让使用者缓解湿寒凉所带来的各种不适,使血管更富有弹性,骨密度更高,而且在浸泡后未检测出重金属;进一步的,可以将能量石本体佩戴在身上,也可以用于刮痧,还可以做成美容棒,进行面部美容。
上述虽然对本发明的具体实施例作了详细说明,但是本发明并不限于上述实施例,在本领域普通技术人员所具备的知识范围内,还可以在不脱离本发明宗旨的前提下做出各种变化,而不具备创造性劳动的修改或变形仍在本发明的保护范围以内。
Claims (6)
1.一种不溶于水但可以释放偏硅酸的能量石,其特征在于,包括能量石本体,所述能量石本体内含有Si、Fe、Cu、Zn和Pb元素,所述Si元素为SiO2,所述Fe元素为FeO,所述Cu元素为CuO,所述Zn元素为ZnO,所述Pb元素为PbO。
2.根据权利要求1所述的一种不溶于水但可以释放偏硅酸的能量石,其特征在于:所述Si元素含量为999789.19ppm,所述SiO2含量为999934.32ppm。
3.根据权利要求1所述的一种不溶于水但可以释放偏硅酸的能量石,其特征在于:所述Fe元素含量为157.68ppm,所述FeO含量为50.24ppm。
4.根据权利要求1所述的一种不溶于水但可以释放偏硅酸的能量石,其特征在于:所述Cu元素含量为12.82ppm,所述CuO含量为3.94ppm。
5.根据权利要求1所述的一种不溶于水但可以释放偏硅酸的能量石,其特征在于:所述Zn元素含量为22.26ppm,所述ZnO含量为6.78ppm。
6.根据权利要求1所述的一种不溶于水但可以释放偏硅酸的能量石,其特征在于:所述Pb元素含量为18.06ppm,所述PbO含量为4.73ppm。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210486033.6A CN114715999A (zh) | 2022-05-09 | 2022-05-09 | 一种不溶于水但可以释放偏硅酸的能量石 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210486033.6A CN114715999A (zh) | 2022-05-09 | 2022-05-09 | 一种不溶于水但可以释放偏硅酸的能量石 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114715999A true CN114715999A (zh) | 2022-07-08 |
Family
ID=82230436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210486033.6A Pending CN114715999A (zh) | 2022-05-09 | 2022-05-09 | 一种不溶于水但可以释放偏硅酸的能量石 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114715999A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1161310A (zh) * | 1996-10-04 | 1997-10-08 | 吴从善 | 纳米固体材料复合元素净水珠 |
WO2016038175A1 (fr) * | 2014-09-11 | 2016-03-17 | Phyco- Biotech | Composition comprenant une microalgue enrichie en silicium pour une utilisation therapeutique |
WO2016100903A2 (en) * | 2014-12-19 | 2016-06-23 | The Texas A&M University System | Hybrid activated iron-biological water treatment system and method |
WO2021217568A1 (zh) * | 2020-04-30 | 2021-11-04 | 四川三泰医药科技有限公司 | 用于美容养颜的组装玉石活化材料及其组装合成方法和用途 |
-
2022
- 2022-05-09 CN CN202210486033.6A patent/CN114715999A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1161310A (zh) * | 1996-10-04 | 1997-10-08 | 吴从善 | 纳米固体材料复合元素净水珠 |
WO2016038175A1 (fr) * | 2014-09-11 | 2016-03-17 | Phyco- Biotech | Composition comprenant une microalgue enrichie en silicium pour une utilisation therapeutique |
WO2016100903A2 (en) * | 2014-12-19 | 2016-06-23 | The Texas A&M University System | Hybrid activated iron-biological water treatment system and method |
WO2021217568A1 (zh) * | 2020-04-30 | 2021-11-04 | 四川三泰医药科技有限公司 | 用于美容养颜的组装玉石活化材料及其组装合成方法和用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Munteanu et al. | Mud therapy and rehabilitation-scientific relevance in the last six years (2015–2020) Systematic literature review and meta-analysis based on the PRISMA paradigm | |
Sarker et al. | Halite; The rock salt: Enormous health benefits | |
CN108403479A (zh) | 一种祛皱美白抗过敏火山泥面膜及其制备方法 | |
CN114715999A (zh) | 一种不溶于水但可以释放偏硅酸的能量石 | |
CN101643255A (zh) | 一种微电解类活水材料及其制备方法 | |
CN106902342A (zh) | 一种泡脚迷你包及其制备方法 | |
CN104291794A (zh) | 一种能产生微电流的负离子颗粒材料 | |
CN109179620B (zh) | 一种组合式多功能养生富氢水片 | |
CN105985892A (zh) | 一种黑蚁保健酒及制备方法 | |
CN103356457A (zh) | 一种银杏叶化妆水 | |
CN104278543A (zh) | 一种包括负离子颗粒的染料 | |
CN104594048A (zh) | 包括具有产生微电流的负离子颗粒的纱线 | |
KR20190025271A (ko) | 손가락 교정기 | |
CN107373316A (zh) | 一种提升睡眠质量及增强脑功能的纯植物仿生肉及其加工方法 | |
Schilling et al. | Work performance at altitude after adaptation in man and dog | |
CN111407005A (zh) | 一种基于不温变远红外芯片的保健养生衣 | |
Finlay et al. | Post-swim orthostatic intolerance in a marathon swimmer | |
Walker | Etiology of nutritional rickets: geographic variations | |
CN1029767C (zh) | 甲鱼冻的加工方法 | |
CN107789117A (zh) | 粗盐热敷贴 | |
CN107487800A (zh) | 一种多功能陨石活化水、用途及其制备方法 | |
Chien et al. | The effect of total-body X-irradiation on the circulation of splenectomized dogs | |
CN106994165A (zh) | 一种鹿茸含片 | |
Lee et al. | Leisure-time Running And All-cause Cancer Mortality: 1874 Board# 26 June 2, 3: 30 PM-5: 00 PM | |
CN106389301A (zh) | 一种美容保健中药面膜 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220708 |
|
WD01 | Invention patent application deemed withdrawn after publication |